Engineering Novel First-in-Class Biologics
Designing platforms to lend novel functionality and improvements in developability requires a high degree of innovation to address hard to reach and difficult targets. The PEGS Engineering stream provides knowledge and collaboration opportunities
for scientists in this highly competitive field. Display and engineering of biologics including bispecific antibodies will be highlighted for applications in oncology, immunotherapy, infectious disease, CNS, inflammation and autoimmune disorders.